This cohort proposes that the role of a high MIB-1 index (>3%) as a key factor associated with meningioma recurrence is limited compared with the literature (20-24) and only the combination with WHO grade III histology (anaplastic or atypical) may increase the risk of tumor recurrence. Here, MIB1 is linked to neoplasm.